Ivor MacLeod
Director of Finance/CFO presso SCYNEXIS, INC.
Patrimonio netto: 235 506 $ in data 31/03/2024
Profilo
Ivor MacLeod is currently the Chief Financial & Accounting Officer at SCYNEXIS, Inc. Prior to this, he held positions as Vice President-Finance at Merck & Co., Inc., Vice President-Finance & Information Technology at Hoffmann-La Roche, Inc., and Chief Financial & Compliance Officer, SVP at Eisai, Inc. From 2021 to 2022, he served as the Chief Financial & Accounting Officer at Athersys, Inc. Mr. MacLeod completed his undergraduate degree at the University of St. Andrews and holds an MBA from Eller College of Management.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
SCYNEXIS, INC.
0.43% | 26/01/2024 | 160 185 ( 0.43% ) | 235 472 $ | 31/03/2024 |
ATHERSYS, INC.
0.01% | 14/08/2023 | 5 732 ( 0.01% ) | 34 $ | 31/03/2024 |
Posizioni attive di Ivor MacLeod
| Società | Posizione | Inizio |
|---|---|---|
| SCYNEXIS, INC. | Director of Finance/CFO | 24/10/2022 |
Precedenti posizioni note di Ivor MacLeod
| Società | Posizione | Fine |
|---|---|---|
| ATHERSYS, INC. | Director of Finance/CFO | 30/06/2022 |
| MERCK & CO., INC. | Director of Finance/CFO | - |
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Director of Finance/CFO | - |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Director of Finance/CFO | - |
Formazione di Ivor MacLeod
| University of St. Andrews | Undergraduate Degree |
| Eller College of Management | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| SCYNEXIS, INC. | Health Technology |
| ATHERSYS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Health Technology |
- Borsa valori
- Insiders
- Ivor MacLeod
